Coccivac-B52 (Canada)

Company: Merck Animal Health

COCCIDIOSIS VACCINE

Live Oocysts

DIRECTIONS FOR USE, READ CAREFULLY

Description

This product contains live oocysts of the following species of coccidia: E. acervulina, E. maxima, E. maxima MFP, E. mivati, and E. tenella.

Coccivac-B52 Indications For Use

This product has been shown to be effective for the vaccination of healthy chickens 1 day of age against coccidiosis due to E. acervulina, E. maxima, E. mivati and E. tenella. Duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Vaccination Programs

Many factors must be considered in determining the proper vaccination program for a particular farm or poultry operation. To be fully effective, the vaccine must be administered to healthy receptive chickens held in a proper environment under good management. In addition, the response may be modified by the age of the chickens and their immune status. Seldom does one vaccination under field conditions produce complete protection for all individuals in a given flock. The amount of protection required will vary with the type of operation and the degree of exposure that a flock is likely to encounter. For these reasons a program of periodic revaccination may be required.

Spray Cabinet Administration

FOR CHICKENS 1 DAY OF AGE

The vaccine should be prepared at the rate of 210 ml of distilled water per 1000 doses of vaccine. Each 100 chicks should receive 21 ml of vaccine solution (dye may be added as a marker).

Full Directions for use of the Spray Cabinet are available from the Company.

Coccivac-B52 Caution

1. VACCINATE ONLY HEALTHY CHICKENS.

2. This product is not ordinarily recommended for use with prestarter or starter feeds containing coccidiostats.

3. Birds must have access to their droppings as reinfection is required to induce immunity.

4. All chickens should be vaccinated at the same time.

5. Use entire contents when first opened.

6. Do not vaccinate within 21 days before slaughter.

7. Store vaccine at 2° to 8° C (35° to 46° F). Do not freeze.

8. Inactivate unused contents before disposal.

9. Do not mix with other products, except as specified on the label.

10. In case of human exposure, contact a physician.

11. Contains gentamicin as a preservative.

12. FOR ANIMAL USE ONLY

Notice

This vaccine has undergone rigid potency, safety and purity tests, and meets Merck Animal Health, U.S. and local requirements. It is designed to stimulate effective immunity when used as directed, but the user must be advised that the response to the product depends upon many factors, including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual chickens and the degree of field exposure. Therefore, directions should be followed carefully.

Records

Keep a record of vaccine, quantity, serial number, expiration date and place of purchase; the date and time of vaccination; the number, age, breed and locations of chickens; names of operators performing the vaccination and any observed reactions.

FEDERAL REGULATIONS PROHIBIT THE REPACKAGING OR SALE OF THE CONTENTS OF THIS CARTON IN FRACTIONAL UNITS. DO NOT ACCEPT IF SEAL IS BROKEN.

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/PCN 1431.5A

1 800 211-3573 (USA)

1 866 683-7838 (Canada)

For patent information:

http://www.merck.com/product/patent/home.html

395080-03

CPN: 1208280.1